A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia

Clinical trial NCT02690714 · COMPLETED

Trial details

NCT number: NCT02690714
Sponsor: Prometic Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypoplasminogenemia Congenital Plasminogen Deficiency

Start date: 2016-05-04
Primary completion: 2017-12-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.